Quest Laboratories Limited

₹84.80As of Sun 8 Nov 2026, 12:00 UTC
NSE:QUESTLABHealthcare
Country India
PE (Fwd) •••
TSR 2Y CAGR (13.24%)
Div yield —
ROE 16.64%
Medical (Pharmaceuticals)
Beta (5Y) 1.02
PE TTM 9.350
TSR TTM (4.88%)
Mkt cap ₹1.390B
ROIC 13.54%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹106
25.50%
(45.53%)
Hold 11|4|4|7|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.43
1.45
1.53
1.62
(3.97%)
(0.44%)
5.76%
15.94%
Revenue₹M
90.23
90.94
92.69
93.42
9.13%
12.13%
10.26%
7.56%
Peers (US$14.80M)
Cap (US$)
PE
8.858M
43.29x
7.067M
16.83x
19.24M
54.62x
Capital
TTM
5Y
10Y
Leveragex
2.051
0.288
0.214
EBIT/Intx
0.370
0.953
0.945
Own earn%
(172.64)
(0.06)
0.92
Sh yield%
31.26
41.96
42.02
Owners
Insiders/Inst%
7.60
80.91
Short interest%
5.61
SBC / revenue%
4.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
30–35
$1 testx
−0.1
Incr. ROIC%
0